TOP TIERMARKET NEWSWIRE
News & sentiment

UROGEN PHARMA LTD (URGN) — News & AI sentiment

UROGEN PHARMA LTD (URGN) news roundup. 1 story in the last 24 hours, 1 in the past week, 8 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $1.2M — net selling of $1.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
1
avg sentiment 50/100
30d stories
8
avg sentiment 59.3/100
Insider net (90d)
$1.2M
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on URGN

20h ago
Jul 22
Jul 20
Jul 17
Jul 12
Jul 12
Jul 8
Jul 1
UroGen Pharma Ltd. (URGN) files 8-K
SEC 8-K50 · neutralgeneral
Jun 23
Jun 14
Jun 10
Jun 5
Jun 2
Jun 2
Jun 2
Jun 1
May 23
May 17
Urogen Pharma Q1 Earnings Call Highlights
Yahoo Top63 · neutralearnings
May 7
Open URGN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →